BSE filing, NSE: SAKSOFT. Summary written from the filing by ALFA Finder's alert engine.
Saksoft Ltd: key numbers
- Share price
- ₹132.95
- Market cap
- ₹1,762 Cr
- Revenue (annual)
- ₹1,007 Cr
- Net profit (annual)
- ₹133.3 Cr
- P/E (TTM)
- 13.5×Sector 23.0×
- Promoter holding
- 66.72%+0.00% QoQ
- FII holding
- 1.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saksoft Ltd
All →Saksoft Board Meeting Date
Saksoft schedules a 04 Nov 2026 board meeting on Q2 results and an interim dividend. Interim dividend record date is 10 Nov 2026.
Saksoft Other Announcement
Saksoft Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR regulations.
Saksoft Annual General Meeting
Saksoft issued a postal ballot to amend its ESOP 2009 plan and grant 66.28 lakh options to its subsidiary CEO. Voting closes November 14, 2026.
Saksoft Merger & Restructuring
Saksoft Limited received a rectified order from the NCLT Chennai Bench correcting factual details in the sanctioned Scheme of Amalgamation of its wholly-owned subsidiary, Augmento Labs.
Saksoft Credit Rating
Care Ratings Limited has upgraded the credit rating for Saksoft Limited's long-term bank facilities to 'CARE A+; Stable'. Short-term bank facilities rating remains 'CARE A1'.
Saksoft Management Change
Saksoft Limited has appointed Mr. Gurmeet Chahal as Chief Executive Officer of its material subsidiary, Saksoft Inc. (US). He will also serve as Senior Management Personnel.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date